Understanding the biology of melanoma heterogeneity with a goal to improve therapies. #tumor_spheroids #microscopy #scitweets #FUCCI
Australia
Joined August 2018
- Tweets862
- Following415
- Followers862
- Likes2.7K
Haass_Melanoma_lab retweeted
TRI explored melanoma, the immune system, prostate, bladder and childhood brain cancer - as part of a mini-symposium today. Thanks Dr Mitchell Lawrence at @MonashUni, @srilakshmisri13, @HaassLab, Elysse Morris, Dr Liam O'Brien, @OzEDW, @BockNat. @QUT, @UQ_News, @MaterResearch.
Haass_Melanoma_lab retweeted
🎁Interested in reading more about the study? Here is the Research Briefing describing the authors' and an expert's view, but also the editor's perspective on the findings and their importance. #microtubule #mechanobiology
👉🏽rdcu.be/dTAaS
nature.com/articles/s41556-0…
Haass_Melanoma_lab retweeted
Team science wins again. This project epitomises what can be achieved when the right group of people are proud together. Huge congratulations to @MelanomaACEMID team!!
🏆 ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis @MelanomaACEMID @UQMedicine is awarded the @BizEventsPerth Eureka Prize for Excellence in Interdisciplinary Scientific Research. #EurekaPrizes
Learn more: youtu.be/VV7x9SlGupw
Haass_Melanoma_lab retweeted
@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/
@MelanomaAus
Haass_Melanoma_lab retweeted
@HaassLab is a clinical scientist and academic leader at #FrazerInstUQ @UQMedicine @TRI_info. Hear his talk ‘Re-sensitisation of resistant patients to immune checkpoint therapy’ at the 2024 MASC Trials ASM, 24 October 2024, Sydney. Register: masc.org.au/asm-2024/
@MelanomaAus
Haass_Melanoma_lab retweeted
Great talk by A/Prof Aideen McInerney-Leo, from UQ, about the importance of Mainstreaming Melanoma Genetic Testing in Australia. @Amcinerneyleo @AsdrResearch @CTSR_USyd
Haass_Melanoma_lab retweeted
Prof @DrJonasANilsson, Keynote Speaker at the ASDR2024 Session 6, talking about cell therapy for therapy-resistant metastatic melanoma. @AsdrResearch @CTSR_USyd
Haass_Melanoma_lab retweeted
Former @AsdrResearch president Prof Nikolas Haass gave the prestigious Ross Barnetson Lecture @AsdrResearch #ASDR2024
👏👏👏👏👏👏👏👏👏👏👏👏👏
Haass_Melanoma_lab retweeted
The sun is rising over ASDR2024. It’s going to be an exciting few days here @WestmeadHub @WestmeadInst for Dermatology research @AsdrResearch. It’s all about to begin!
Haass_Melanoma_lab retweeted
Day 1 at the Australasian Society for Dermatology #research conference was fantastic!
Inspiring talks, great poster presentations, networking & exciting new discoveries.
A great start to an amazing event! Looking forward to Day 2
@AsdrResearch
Haass_Melanoma_lab retweeted
So, it turns out that we now can do Western blot from single cells. Cool !
At least it worked for them in #cancer cells.
Full story @NatureComms nature.com/articles/s41467-0…
Haass_Melanoma_lab retweeted
This year’s NAIDOC Week theme, “Keep the Fire Burning! Black, Loud & Proud,” honours and celebrates the strength and vitality of First Nations culture.
Visit naidoc.org.au.
Visit our Aboriginal and Torres Strait Islander engagement webpage dermcoll.edu.au/about/aborig…
Haass_Melanoma_lab retweeted
ASDR2024 is ready to welcome you in Sydney, 18-20 July 2024. Abstract submissions are closed. Registration is still open, but only 20 places left. Be quick to register before you miss it. Link: asdr.org.au/asdr-2024 @AsdrResearch
Haass_Melanoma_lab retweeted
Have a look at what we have in store for the second day of our 56th Annual Scientific Meeting. For the full program, go to acdasm.com.au/ #ACDASM2024
Haass_Melanoma_lab retweeted
Thank you @DermatologyACD for giving @AsdrResearch the opportunity to join #ACDASM2024 in Perth.
@Amcinerneyleo Prof Johannes Kern
@UQDRC @UQMedicine
#DermatologyResearch #ClinicianResearcherCollaboration
Haass_Melanoma_lab retweeted
Clinical trial discoveries to be the focus of Melanoma & Skin Cancer Trials 2024 Annual Scientific Meeting, 24 Oct, Hyatt Regency Sydney. Register: masc.org.au/asm-2024/
@UTS_CQUEST @MelanomaAus @MelanomaACEMID @DrVictoriaMar @kiakho @HaassLab @ProfSNicholls @DWhitemanQIMRB
Haass_Melanoma_lab retweeted
Congratulations to TRI’s 2024 #Translation Fellows: Dr @ChandraJanin from @UQ_News, Dr @BockNat
from @QUT, Dr @john_kemp from @MaterResearch
and Dr Kyle White from @pahospital. @MaterNews
@MetSthHealth #FrazerInstUQ. Read more: bit.ly/44sDrcY
Haass_Melanoma_lab retweeted
Australasian Society for Dermatology Research (ASDR), announce the ASDR 2024 Annual Scientific Meeting. This will take place from 18th-20th July 2024 at Westmead Innovation Centre, Sydney, NSW, Australia.
EARLYBIRD REGISTRATIONS CLOSE: 6 JUNE
ABSTRACT SUBMISSIONS CLOSE: 23 MAY
Haass_Melanoma_lab retweeted
Abstract/Rego open. @AsdrResearch @HaassLab @sydFMH_EMCR @WestmeadInst @WestmeadHub @CPC_Westmead @SydCancerPtnrs @DermatologyACD
I have the privilege to act as Secretary to the @AsdrResearch ASDR 2024 meeting held here @ Westmead Innovation Centre, 18-20 Jul 2024. Abstract/Rego open asdr.org.au/asdr-2024. I promise it will be a great event.
Haass_Melanoma_lab retweeted
👁️ Join us for the 2024 Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit on Sat 15 June. Registration is free & open to anyone in the world. masc.org.au/aoma-summit/
@SarahCoupland3 @OlofssonBagge @MattCarlino @AnthonyMJoshua @DrJonasANilsson @DrDamienKee @LotteSFog